Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets OTCPK - Delayed Quote USD

DRI HEALTHCARE TR (DHTRF)

Compare
8.21
0.00
(0.00%)
As of April 16 at 4:00:00 PM EDT. Market Open.
Loading Chart for DHTRF
  • Previous Close 7.74
  • Open 7.74
  • Bid 7.87 x 40000
  • Ask 8.57 x 40000
  • Day's Range 7.74 - 7.74
  • 52 Week Range 7.54 - 12.40
  • Volume 100
  • Avg. Volume 403
  • Market Cap (intraday) 462.098M
  • Beta (5Y Monthly) 0.54
  • PE Ratio (TTM) --
  • EPS (TTM) -0.06
  • Earnings Date May 5, 2025 - May 9, 2025
  • Forward Dividend & Yield 0.40 (4.87%)
  • Ex-Dividend Date Mar 31, 2025
  • 1y Target Est --

DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.

www.dricapital.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: DHTRF

View More

Performance Overview: DHTRF

Trailing total returns as of 4/17/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

DHTRF
1.00%
S&P/TSX Composite index (^GSPTSE)
2.08%

1-Year Return

DHTRF
31.66%
S&P/TSX Composite index (^GSPTSE)
11.33%

3-Year Return

DHTRF
8.82%
S&P/TSX Composite index (^GSPTSE)
10.31%

5-Year Return

DHTRF
8.82%
S&P/TSX Composite index (^GSPTSE)
67.90%

Compare To: DHTRF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: DHTRF

View More

Valuation Measures

Annual
As of 4/16/2025
  • Market Cap

    438.66M

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    35.09

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.34

  • Price/Book (mrq)

    0.88

  • Enterprise Value/Revenue

    5.48

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -1.80%

  • Return on Assets (ttm)

    3.23%

  • Return on Equity (ttm)

    -0.62%

  • Revenue (ttm)

    186.98M

  • Net Income Avi to Common (ttm)

    -3.36M

  • Diluted EPS (ttm)

    -0.06

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    36.5M

  • Total Debt/Equity (mrq)

    81.91%

  • Levered Free Cash Flow (ttm)

    -171.36M

Research Analysis: DHTRF

View More

Company Insights: DHTRF

Research Reports: DHTRF

View More

People Also Watch